143 related articles for article (PubMed ID: 7667607)
61. Neurohypophysial hormone secretion in hyperprolactinaemic women.
Laczi F; Szasz A; Vecsernyes M; Julesz J
Neuropeptides; 1998 Oct; 32(5):435-7. PubMed ID: 9845004
[TBL] [Abstract][Full Text] [Related]
62. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
Hattori N
J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
[TBL] [Abstract][Full Text] [Related]
63. Lack of plasma prolactin response to intravenously injected vasoactive intestinal polypeptide in patients with prolactin-secreting adenoma.
Kaji H; Chihara K; Kita T; Kashio Y; Okimura Y; Fujita T
Acta Endocrinol (Copenh); 1985 Dec; 110(4):445-50. PubMed ID: 4090907
[TBL] [Abstract][Full Text] [Related]
64. The Beckman DxI 800 prolactin assay demonstrates superior specificity for monomeric prolactin.
Byrne B; O'Shea P; Barrett P; Tormey W
Clin Chem Lab Med; 2010 Feb; 48(2):205-8. PubMed ID: 19943807
[TBL] [Abstract][Full Text] [Related]
65. [Importance of prolactin isoforms on ovary function in hyperprolactinemic women].
Romero C; León J; Jara R; González O
Rev Chil Obstet Ginecol; 1993; 58(6):465-9. PubMed ID: 7991872
[TBL] [Abstract][Full Text] [Related]
66. [Heterogeneity of immunoreactive prolactin in hyperprolactinemia of various origin].
Bulatov AA; Makarovskaia EE; Dzeranova LK; Smirnova NB; Chernogolov VA; Marova EI; Mel'nichenko GA; Dedov II
Probl Endokrinol (Mosk); 1992; 38(6):13-6. PubMed ID: 1302839
[TBL] [Abstract][Full Text] [Related]
67. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
68. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Moriondo P; Travaglini P; Nissim M; Faglia G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
[TBL] [Abstract][Full Text] [Related]
70. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
[TBL] [Abstract][Full Text] [Related]
71. Molecular heterogeneity of circulating prolactin in chronic uremic men and renal transplant recipients.
Rodríguez-Puyol D; Martín-Oar JE; Cachofeiro MV; del Pino D; López-Novoa JM; Hernando L
J Clin Endocrinol Metab; 1986 Feb; 62(2):352-6. PubMed ID: 3079774
[TBL] [Abstract][Full Text] [Related]
72. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
73. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
[TBL] [Abstract][Full Text] [Related]
74. Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma.
Guido R; Valenti S; Foppiani L; De Martini D; Cossu M; Giusti M
J Endocrinol Invest; 1997 May; 20(5):289-93. PubMed ID: 9258810
[TBL] [Abstract][Full Text] [Related]
75. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients.
Mok CC; Lau CS; Tam SC
Br J Rheumatol; 1997 Sep; 36(9):986-9. PubMed ID: 9376996
[TBL] [Abstract][Full Text] [Related]
76. Prolactin and macroprolactin: a case report of hyperprolactinaemia highlighting the interpretation of discrepant results.
Ismail AA; Walker PL; Fahie-Wilson MN; Jassam N; Barth JH
Ann Clin Biochem; 2003 May; 40(Pt 3):298-300. PubMed ID: 12803849
[TBL] [Abstract][Full Text] [Related]
77. Prolactin bioassay and hyperprolactinemia.
Peabody CA; Schultz PN; Warner MD; Worsley IG; Friesen HG; Samaan NA
J Endocrinol Invest; 1992; 15(7):497-9. PubMed ID: 1360020
[TBL] [Abstract][Full Text] [Related]
78. Altered diurnal rhythm of prolactin in systemic sclerosis.
Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
[TBL] [Abstract][Full Text] [Related]
79. Bone mineral content in normally menstruating women with hyperprolactinaemia.
Nyström E; Leman J; Lundberg PA; Lindquist O; Hansson T; Bengtsson C; Rybo G; Lindstedt G
Horm Res; 1988; 29(5-6):214-7. PubMed ID: 3220459
[TBL] [Abstract][Full Text] [Related]
80. Prevalence of macroprolactin detected by Elecsys 2010.
Sánchez-Eixerés MR; Mauri M; Alfayate R; Graells ML; Miralles C; López A; Picó A
Horm Res; 2001; 56(3-4):87-92. PubMed ID: 11847468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
